MetLife Investment Management, LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$384,489

-$137,159 QoQ

Shares Held

55,562

+294.3% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 126 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. RLMD ranks #146 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$384,489	55,562	+294.3%	Shares	Defined	2026-08-14
2022-09-30	$521,648	14,091	0.0%	Shares	Defined	2024-05-10
2022-06-30	$267,588	14,091	0.0%	Shares	Defined	2024-05-10
2022-03-31	$380,316	14,091	+108.6%	Shares	Defined	2024-05-10
2021-12-31	$152,167	6,754	0.0%	Shares	Defined	2024-05-17
2021-09-30	$177,022	6,754	0.0%	Shares	Defined	2024-05-17
2021-06-30	$216,195	6,754	0.0%	Shares	Defined	2024-05-17
2021-03-31	$237,808	6,754	0.0%	Shares	Defined	2024-05-17
2020-12-31	$216,600	6,754	0.0%	Shares	Defined	2024-05-24
2020-09-30	$254,085	6,754	0.0%	Shares	Defined	2024-05-24
2020-06-30	$302,241	6,754	—	Shares	Defined	2024-05-24
No filing history on record for this holder in this stock.